Abrupt Vision Loss in One Eye: Vascular and Inflammatory Causes

Vascular Causes

• The American College of Cardiology recommends immediate stroke center transfer within 4.5 hours for potential thrombolysis in patients with central retinal artery occlusion (CRAO), an ocular stroke equivalent 1, 2, 3
• Branch retinal artery occlusion (BRAO) causes sectoral vision loss and requires urgent stroke evaluation within 24 hours 2
• Up to 25% of CRAO patients have concurrent silent brain infarction on MRI, and up to 70% have significant carotid stenosis 2
• Risk factors for CRAO include cardiovascular disease, hypertension, diabetes, hyperlipidemia, and smoking 2
• The American Heart Association recommends that stroke risk remains highest in the first 7 days even if vision improves, and never assume reperfusion eliminates stroke risk 2

Inflammatory/Arteritic Causes

• The American College of Rheumatology recommends considering giant cell arteritis (GCA) in all patients over 50 years with sudden vision loss 2
• Jaw claudication is the most specific symptom of GCA, followed by scalp tenderness, temporal tenderness, headaches, and constitutional symptoms 1, 2
• ESR >60 mm/h has a high likelihood ratio for GCA diagnosis 1, 2
• The American College of Rheumatology recommends starting empiric high-dose steroids immediately in suspected GCA cases to prevent vision loss in the contralateral eye 2

Optic Nerve Causes

• The American Academy of Neurology recommends evaluating patients with optic neuritis for multiple sclerosis, neuromyelitis optica, or other demyelinating conditions 4, 2
• MRI of orbits and brain with contrast evaluates for optic nerve enhancement and intracranial demyelinating lesions 4

Critical Diagnostic Approach

• The American Academy of Ophthalmology recommends documenting visual acuity with current correction as first priority 3
• Assessing for relative afferent pupillary defect (RAPD) indicates significant retinal or optic nerve dysfunction 3
• Evaluating pupil size, shape, and reactivity—slow or poorly reactive pupils suggest significant retinal or optic nerve pathology 3
• Checking red reflex bilaterally—any asymmetry indicates serious pathology 3
• Performing fundus examination and visual fields by confrontation 3
• Brain MRI with diffusion-weighted imaging identifies concurrent stroke in up to 24% of retinal vascular events 1, 2
• Vascular imaging (CTA or MRA) assesses carotid stenosis 1, 2
• ESR and CRP should be evaluated in all patients over 50 years to assess for giant cell arteritis, regardless of whether classic symptoms are present 1, 2

Differential Diagnosis for Sudden Painless Monocular Vision Loss

Primary Differential Diagnoses

• The American Heart Association defines central retinal artery occlusion (CRAO) as an acute ischemic stroke equivalent, requiring immediate emergency department evaluation, with a natural history of only 17% achieving functional visual acuity in the affected eye 5, 6
• CRAO results from thromboembolic disease in 95% of cases, with major risk factors including hypertension and hyperlipidemia, and up to 40% of patients having ≥70% ipsilateral carotid stenosis 5, 6, 7
• The American College of Cardiology recommends considering CRAO in patients with sudden, painless monocular vision loss, with a high index of suspicion for arteritic causes, such as giant cell arteritis (GCA), in patients over 50 years 5, 6

Vascular Causes

• Branch retinal artery occlusion (BRAO) typically causes sectoral rather than complete vision loss, presenting with corresponding visual field defect rather than near-total vision loss 8, 9
• Ophthalmic artery occlusion is more severe than CRAO, affecting both retinal and choroidal circulation, and presents with complete vision loss and may have associated ocular pain 7
• Retinal vein occlusion (central or branch) typically presents with hemorrhages and venous tortuosity on fundoscopy, not the pale retina of arterial occlusion, and is associated with hypertension and hyperlipidemia but usually has better initial visual acuity 9

Critical Diagnostic Pitfalls

• The American Academy of Ophthalmology recommends that eye care providers serve as "gate-keepers" for rapid diagnosis of ocular stroke, then immediately refer to a stroke center, without attempting further testing in the office 8, 10
• The American Heart Association recommends recognizing CRAO as a stroke equivalent requiring stroke protocol, with brain MRI with diffusion-weighted imaging, vascular imaging, and cardiac monitoring within 24 hours 5, 6, 11, 12

Urgent Evaluation and Management of Giant Cell Arteritis in Patients ≥ 50 Years with New Visual Symptoms

Immediate GCA Assessment

• All patients ≥ 50 years presenting with new visual phenomena (floaters, photopsias) should undergo urgent giant cell arteritis (GCA) evaluation, even in the absence of classic systemic symptoms. – American College of Rheumatology (ACR) recommendation; evidence level not specified. [13][14]
• The coexistence of visual symptoms and light‑headedness may indicate cerebral ischemia secondary to large‑vessel vasculitis and should trigger immediate GCA work‑up. – ACR; evidence level not specified. [13][14]

Laboratory Testing

• Obtain erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP) without delay in every patient ≥ 50 years with suspected GCA. – ACR; evidence level not specified. [13][14]
• Do not await laboratory results before initiating high‑dose corticosteroid therapy when clinical suspicion for GCA is high. – ACR; evidence level not specified. [13][14]

Key Clinical Features to Screen

• Persistent new‑onset temporal headache is a common presenting feature of GCA. – ACR; evidence level not specified. [13][14]
• Constitutional manifestations such as ≥ 2 kg weight loss, low‑grade fever, fatigue, and night sweats support the diagnosis. – ACR; evidence level not specified. [13][14]
• Symptoms of polymyalgia rheumatica (proximal muscle stiffness and pain) frequently accompany GCA. – ACR; evidence level not specified. [13][14]

Immediate Therapeutic Action

• Start high‑dose corticosteroids immediately once GCA is suspected, prior to biopsy or imaging confirmation, to prevent involvement of the contralateral eye. – ACR; evidence level not specified. [13][14]
• Delaying corticosteroid therapy in the presence of visual symptoms is the strongest predictor of permanent blindness. – ACR; evidence level not specified. [13][14]

Referral, Imaging, and Biopsy

• Arrange urgent referral (within 24 h) to a specialist team capable of performing temporal‑artery biopsy and vascular imaging. – ACR; evidence level not specified. [13][14]
• When GCA is suspected, temporal‑artery ultrasound or MRI should be obtained promptly to aid diagnosis. – ACR; evidence level not specified. [13][14]

Neurologic Evaluation for Light‑Headedness

• Any patient with combined visual symptoms and light‑headedness warrants assessment for cerebral ischemia (e.g., stroke work‑up). – ACR; evidence level not specified. [13][14]

Other Vascular/Inflammatory Differentials (Cited)

Systemic Causes of Light‑Headedness (Cited)

• Orthostatic hypotension – assess with orthostatic vital signs. – Radiology Society guideline; evidence level not specified. 16
• Cardiac arrhythmias – evaluate with ECG/monitoring. – Radiology Society guideline; evidence level not specified. 15
• Anemia – screen with complete blood count. – Radiology Society guideline; evidence level not specified. 15

Patient Safety‑Netting

• Patients must return immediately for any worsening light‑headedness or new neurologic symptoms, as these may signal evolving cerebral ischemia. – ACR; evidence level not specified. [13][14]
• If GCA is suspected, specialist evaluation should occur within 24 hours. – ACR; evidence level not specified. [13][14]